Skip to content

GCRI · Health Nexus

Molecular and life sciences for health threats

Molecular and life sciences characterise the pathogens, hosts and vectors behind health threats: their genomes, how they evolve, how they resist drugs and how they move between species. In this field they supply the laboratory and genomic evidence that confirms an event, links cases and tracks resistance across human, animal and environmental samples.

01تۆمارکردن

Molecular and life sciences for health threats on the record.

Method recordSTEM method
  1. ڕێگازانستی مۆلیکیوڵی و ژیان
  2. Applied inHealth Nexus
  3. Canonical pageSTEM Commons
02بەکارهێنان

What molecular and life sciences does here.

Molecular and life sciences study the structure and function of living systems from genes and proteins to cells and organisms. They underpin the understanding of pathogens, resistance, toxicity and biological innovation. In health and biosecurity, life sciences support pathogen characterisation, antimicrobial resistance tracking and biosecurity assessment. They inform how biological threats might spread through health, agriculture and trade. The canonical description is on the STEM Commons.

Genomic surveillance of pathogens

Sequences from clinical, animal and environmental samples are assembled, assigned to lineages and placed on phylogenies to identify variants and assess relatedness, with sampling coverage reported beside every tree.

Cross-species linkage in One Health

Pathogen and resistance-gene sequences from people, livestock and the environment are compared to assess whether they share a source, under agreed sampling and metadata standards.

Wastewater and environmental surveillance

Nucleic acid targets in wastewater are measured and normalised for flow and population markers to follow community infection trends independently of who seeks testing.

03واژۆی کەرت

The sector signature of molecular and life sciences for health threats.

The sectors molecular and life sciences for health threats touches and how strongly they depend on each other: what a study has to observe and model together.

گۆشەکان هەڵبژێرە · بەسەر هێڵەکاندا ڕابوەستە6 / 15 پەیوەندی

واژۆ

تەندروستی و هاوبەشەکانی

تەندروستی هێزی کار بۆ کارپێکردن دەداتە ژێرخان (0.3)، کرێکاری کێڵگە دەداتە خۆراک (0.3) و کارمەندی خزمەتگوزاری دەداتە ئاو (0.2).

W · E · I · F · H · B

کەرتەکان
4 لە 6
پەیوەندییەکان
6 لە 15
هاوبەستی
0.42 بەشی کۆی گشتی

بەهێزترین پەیوەندییەکانی لە کاردا

  • ئاو → خۆراک · ئاودێری0.8
  • خۆراک → تەندروستی · خۆراکپێدان0.7
  • ژێرخان → ئاو · بۆری، بەربەست و پاڵاوگە0.6
  • ئاو → تەندروستی · ئاوی خواردنەوە و پاکوخاوێنی0.7
بەهای فێرکاری بۆ ناوچە-شارێکی ئاسایی، نەک پێوانە بۆ هیچ شوێنێک. هاوبەستی کۆی بەهێزی ئەو پەیوەندییانەیە کە لە کاردان، وەک بەشێک لە هەر پانزەکە.
04داتا

What the method consumes.

Datasets and records used by molecular and life sciences on this platform, with the role each plays and the label its values carry. Sources are listed in the source register.

داتاڕۆڵناونیشان
INSDC archives (GenBank, ENA, DDBJ)Reference and outbreak sequencesچاودێریکراو
GISAIDInfluenza and coronavirus genomes with metadataچاودێریکراو
WHO GLASSResistance phenotypes from laboratory surveillanceڕاپۆرتکراو
Wastewater sampling programmesCommunity trend signalsچاودێریکراو
05ڕێگا و بەڵگە

How molecular and life sciences for health threats is modelled, measured and tested.

مۆدێلەکە، گریمانەکانی، داتاکانی و نادڵنیاییەکەی، بەو شێوەیەی زانا یان ئەندازیارێک دەیپشکنێت. پێکهاتەکان ڕێگا بڵاوکراوەکان دەگرنەبەر. بەهاکانی کێشراو نموونەییە، نەک دۆزینەوە.

بەندەکانی نادڵنیایی

How far the outlook for molecular and life sciences for health threats could spread, shown as ranges rather than a single line.

ئێستا+5+10+15+20+25+30 yبەرزنزمڕێژەی زۆر ئەگەردارمەودای ئەگەردار
مەزەندەی ناوەندی
ناوەندیی کۆمەڵەی مۆدێلەکان
مەودا
ئەگەردار و زۆر ئەگەردار، بە زمانی پێوانەکراوی IPCC
کۆمەڵە
ئەندام، سیناریۆ و مەرجە سەرەتاییەکان ڕاگەیەندراون
لەگەڵ ئەمە بخوێنەوە
هەستیاریی ئەنجام بەرامبەر بە هەر تێکردنێک
بڵاوبوونەوەی کۆمەڵەی نموونەیی لەسەر پێوەرێکی ئیندێکس؛ شێوەکە ڕێنمایی نادڵنیایی IPCC دەگرێتەبەر. پێشبینی نییە.
FAIR guiding principles · GO FAIR and FORCE11W3C PROV · World Wide Web ConsortiumGuidance on consistent treatment of uncertainties · IPCCCEOS Analysis Ready Data · Committee on Earth Observation Satellites
06پشتڕاستکردنەوە

How results are checked.

Results are confirmed through biological replicates, independent laboratories and orthogonal assays. Reference standards and proficiency testing check analytical accuracy.

بپشکنەHow it is done
External quality assessmentLaboratories take part in proficiency testing and use reference materials for each assay
Sampling representativenessHow sequenced samples were selected is reported, so lineage shares are not over-read
Phylogenetic robustnessTrees are tested with bootstrap or posterior support and alternative models before relatedness is described

Laboratory findings do not always translate to organisms or populations. Sampling bias in sequence databases limits generalisation.

07پرۆسە

چۆن پرۆسەکە کار دەکات.

Process explorer · Process

Molecular and life sciences for health threats: Life-science research oversight

7 steps3 stages2 gates

پرۆسە

Molecular and life sciences for health threats: Life-science research oversight

Capacity and oversight only, following the WHO Laboratory biosafety manual (4th edition) and WHO life sciences framework, with no methods, agents or protocols.

  1. 01 Institution

    1. 01ProposalDatasetA research institution submits a proposal for review. The place is set by the page.
    2. 02Institutional committeeGate · The institutionA biosafety committee is an independent institutional review group, reporting to senior management. Review follows national rules.
    3. 03Conditions: risk control measuresStepA risk assessment sets the measures: core requirements, heightened control measures or maximum containment, not one biosafety level.
    4. 04Training and competenceStepActual risk depends on the agent, the procedure and staff competency. Training and personnel competence have their own section.
  2. 02 Assurance

    1. 05Audit and inspectionGateMany labs run cooperative inspections: periodic self-audits plus a rarer, deeper evaluation with the biosafety officer or committee.
    2. 06Emergency and incident responseStepThe manual covers emergency and incident response at each level of measures. External reporting of incidents depends on national rules.
  3. 03 National

    1. 07National oversightDecision · District health officeThe WHO framework is for those who govern biorisks, such as policy makers and regulators. National bodies set national rules.

Neutral outline of a published external standard or method, from its issuing body. Not a record of operation. Nexus does not perform, certify or approve any step shown. A gate or decision belongs to the party the source names. The Biological Weapons Convention is not drawn in this flow. The framework is the WHO global guidance framework for the responsible use of the life sciences.

08پەیوەندییەکان

Topics that rely on this method.

09پارێزەرایەتی

Who maintains the method.

Biotechnology and Biosecurity stewards molecular and life sciences for the Consortium and reviews how it is applied across platforms.

10پەیوەست

ئەو شوێنانەی ئەم لاپەڕەیە لە ناو کۆنسۆرتیۆم بۆیان دەبات.

11پرسیارەکان

پرسیار و وەڵام.

What are the limits of molecular and life sciences in this field?
Laboratory findings do not always translate to organisms or populations. Sampling bias in sequence databases limits generalisation.
How are results checked?
Results are confirmed through biological replicates, independent laboratories and orthogonal assays. Reference standards and proficiency testing check analytical accuracy.
Are the values on this page real?
The data names, roles and checks are real descriptions of practice. The canvas shows a design of the method’s use, not a run; no result is reported here.
Where else is this method applied?
The canonical method page lists every platform that applies it.
ڕاپۆرتەکانبەشداربە

لەم لاپەڕەیەوە بەڵگە پێشکەش بکە.

Reports بڵاوکراوەی وەرزیی کۆنسۆرتیۆم ـە. ئەوەی تۆ لەسەر ئەم بابەتە دەیزانیت دەتوانێت لە وەشانی داهاتوودا ببێتە بەڵگە، کەیس یان ڕاستکردنەوە، بە ناوی خۆتەوە و لەژێر CC BY 4.0 بڵاو دەکرێتەوە کاتێک کاری خۆتە.

GCRIHealth NexusGlobal Sector Risk and ResilienceCountry Systems Risk and ResilienceEvidence Brief
Health Nexus

ڕێگایەک، کۆمەڵە داتایەک یان پرسیارێک بهێنە.

زانیاری و پرسیار ئەمڕۆ کراوەن. پرسیارێک ژمارەی ئاماژەی پێدەدرێت و هەنگاوی دواتر دیاری دەکات؛ داواکاری، پارەدان، تەرخانکردنی کۆمپیوتەر و تۆمارکردن تەنیا کاتێک دەکرێنەوە کە تیم، مەرج و توانای پێداچوونەوەیان هەبێت.